SPONSOR

Oslo University Hospital

Total Trials

Recruiting

Phases

Phase 2, Phase 1, Phase 2, Phase 4, Phase 2, Phase 3, Phase 3

Conditions studied: Liver Metastases Colorectal Cancer Anisomelia Deformity of Limb Multiple Sclerosis (MS)Cerebral Small Vessel Diseases Psychotic Disorders Bipolar Disorder Disclosure Plantar Fascitis

Oslo University Hospital is a clinical research sponsor with 19 registered studies on ClinicalTrials.gov, of which 19 are actively recruiting participants. Research covers conditions including Liver Metastases, Colorectal Cancer, Anisomelia, Deformity of Limb.

The trial portfolio spans Phase 2, Phase 1, Phase 2, Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — Oslo University Hospital

How many clinical trials has Oslo University Hospital sponsored?

ClinicalMetric currently tracks 19 clinical trials sponsored by Oslo University Hospital, of which 19 are actively recruiting participants. These trials cover conditions including Liver Metastases, Colorectal Cancer, Anisomelia. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.

What therapeutic areas does Oslo University Hospital research focus on?

Oslo University Hospital clinical trials span Liver Metastases, Colorectal Cancer, Anisomelia, Deformity of Limb, Multiple Sclerosis (MS), and additional conditions. The research pipeline includes Phase 2, Phase 1, Phase 2, Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.

How do I participate in a Oslo University Hospital clinical trial?

To participate in a Oslo University Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Oslo University Hospital trials with current recruitment status updated daily.

Oslo University Hospital

Frequently Asked Questions — Oslo University Hospital

Clinical Trials by Oslo University Hospital

Liver Transplantation Compared to Chemotherapy in Patients With ColoRectal Cancer

RSA Study on the Behaviour of the Growth Plate During and After Temporary Hemi-epiphysiodesis and Epiphysiodesis

MRI-Based Lesion Differentiation in Older Patients With Multiple Sclerosis

Honest Open Proud for Psychotic and Bipolar Disorder in Norway

Treatment of Gastrocnemius Tightness and Subsequent Chronic Plantar Fasciitis with Botulinum Toxin a

Precision Cancer Therapy in Rare Cancers

Mealtime Anxiety in Eating Disorders

Nesiritide in Hypertension

Laryngomalacia, Examinations and Quality of Life in Children Before and After Treatment With Follow-up After 1 Year

Efficacy of rTMS Treatment After Spinal Cord Injury

DSAEK/DMEK and Cystoid Macular Edema - the Role for Topical NSAIDs (Nepafenac) (DMEC)

AlcoTail - Implementation of Tailored Interventions

Home-Based Clinical Management of Cardiac Complications in Systemic Sclerosis

The Relapse from MRD Negativity As Indication for Treatment (REMNANT) Study

Plan of the Day Radiotherapy

Hypofractionated, 3-week, Preoperative Proton or X-ray Radiotherapy for Patients With Localized Soft Tissue Sarcoma

SAINT: Safe Induction of Labor Trial

Novel Technologies to Improve Echocardiographic Estimates of Left Ventricular Filling Pressure in Heart Failure Combined With Atrial Fibrillation

The Role of Functional Magnetic Resonance Imaging in Preoperative Assessment of Primary Penile Carcinoma